Evidence map›Paper›PMID 24827080›Full record

ArticlePediatric cardiology2014

Latent rheumatic heart disease: outcomes 2 years after echocardiographic detection.

Andrea Beaton, Emmy Okello, Twalib Aliku, Sulaiman Lubega, Peter Lwabi, Charles Mondo, Robert McCarter, Craig Sable

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Pediatric cardiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03346525 (The GOAL), which is not on this map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03346525 phase2unknown statusnot on this mapstarted 2018, after this paper: background citation

The GOAL (GwokO Adunu pa Lutino) Trial: Determining the Impact of Penicillin on Latent Rheumatic Heart Disease: A Randomized Controlled Trial in Uganda

TypeinterventionalSponsorChildren's National Research InstituteRan2018 to 2020Enrolled807ConditionsRheumatic Heart Disease in Children, Latent Rheumatic Heart Disease, Rheumatic Heart Disease, Heart DiseasesArmsintramuscular benzathine penicillin G (BPG) prophylaxis
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Rheumatic Heart Disease in the Developing World.Structural heart : the journal of the Heart Team · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Observational
  19. Article
  20. Acute rheumatic fever and rheumatic heart disease.Nature reviews. Disease primers · 2016 · on this map
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Andrea BeatonChildren's National Medical Center, 111 Michigan Avenue NW, Washington, DC, USA, abeaton@cnmc.org.
Emmy Okello
Twalib Aliku
Sulaiman Lubega
Peter Lwabi
Charles Mondo
Robert McCarter
Craig Sable
Uganda Management Institute · UGChildren's National · USMulago Hospital · UG

Funding

Clinical and Translational Science Institute at Children's NationalUL1TR000075 · NCATS · CHILDREN'S RESEARCH INSTITUTE · PI GUAY-WOODFORD, LISA MARIE · 2012 to 2015
$13.7M
NCATS NIH HHS UL1TR000075
6 · The paper itself

Abstract

Screening with portable echocardiography has uncovered a large burden of latent rheumatic heart disease (RHD) among asymptomatic children in endemic regions, the significance of which remains unclear. This study aimed to determine the 2-year outcomes for children with latent RHD diagnosed by echocardiographic screening. Children identified with latent RHD enrolled in a biannual follow-up program. Risk factors for disease persistence and progression were examined. Of 62 children, 51 (82 %) with latent RHD had a median follow-up period of 25 months. Of these 51 children, 17 (33.3 %) reported an interval sore throat or symptoms consistent with acute rheumatic fever (ARF). Of 43 children initially classified as having borderline RHD, 21 (49 %) remained stable, 18 (42 %) improved (to no RHD) and 4 (10 %) worsened to definite RHD. Of the 8 children initially classified as having definite RHD, 6 (75 %) remained stable, and 2 (25 %) improved to borderline RHD. Two children had confirmed episodes of recurrent ARF, one of which represented the sole case of clinical worsening. The risk factors for disease persistence or progression included younger age (p = 0.05), higher antistreptolysin O titers at diagnosis (p = 0.05), and more morphologic valve abnormalities (p = 0.01). After 2 years, most of the children had a benign course, with 91 % remaining stable or showing improvement. Education may improve recognition of streptococcal sore throat. Longer-term follow-up evaluation, however, is warranted to confirm disease progression and risk factor profile. This could help tailor screening protocols for those at highest risk.

Indexed as

Delayed DiagnosisAdolescentChildChild, PreschoolDisease ProgressionEchocardiographyFemaleFollow-Up StudiesHumansMaleMass ScreeningRetrospective StudiesRheumatic Heart DiseaseTime Factors

Identifiers

PMID24827080
OpenAlexW2072980331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.